Marta K.
About Marta K.
Marta K. is a scientist specializing in biotechnology and cancer research, with extensive experience in high-throughput strain engineering and metabolic bottleneck identification. She has worked at several prominent institutions, including Ligand Pharmaceuticals and Genentech, and has authored 11 peer-reviewed publications.
Work at Ligand Pharmaceuticals
Marta K. has been employed as a Scientist at Ligand Pharmaceuticals since 2022. Her role is based in San Diego, California, where she contributes to the company's research initiatives. Ligand Pharmaceuticals focuses on developing innovative therapies, and Marta's expertise in biotechnology supports the organization's objectives.
Previous Experience at Zymergen
Before joining Ligand Pharmaceuticals, Marta K. worked as Scientist III at Zymergen from 2019 to 2021. Her tenure at the company's facility in The Hague, South Holland, Netherlands, involved significant contributions to projects aimed at enhancing microbial strain development and optimization.
Education and Expertise
Marta K. holds a Doctor of Philosophy (PhD) in Molecular Biology from The University of Queensland, which she completed from 2009 to 2013. She also earned a Master of Science (MSc) in Biotechnology from Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, studying from 2002 to 2007. Additionally, she participated in the European Union Socrates/Erasmus Program, studying Bioscience Engineering at KU Leuven in 2006.
Research Contributions and Publications
Marta K. has authored 11 peer-reviewed publications within the fields of biotechnology and cancer research. Her research includes developing workflows for metabolic bottleneck identification and high-throughput generation of multi-edit strains. She has also been involved in discovery and strain optimization projects, specializing in automation for high throughput strain engineering.
Grant Funding and Collaborations
Marta K. has successfully secured $175,000 in lab grant funding through international collaborations. This funding supports her research efforts and contributes to advancements in biotechnology, particularly in the areas of strain engineering and optimization.